Erste Asset Management’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
IC
YCM
VA
BFM
Erste Asset Management's PASG Position: Q2 2026 in Review
Erste Asset Management reduced its Passage Bio (PASG) stake by 52% in Q2 2026, selling an estimated $279K and leaving 40,665 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #557.
Erste Asset Management first reported a position in PASG in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.34M in Q4 2021. 30 funds tracked by Wall St. Rank hold PASG as of Q2 2026.
- Erste Asset Management held 40,665 shares of Passage Bio worth $197K as of Q2 2026.
- Erste Asset Management sold 44,597 Passage Bio shares in Q2 2026, an estimated $279K.
- Passage Bio made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #557 holding.
- Erste Asset Management first reported a position in Passage Bio in Q4 2021 and has held it in 19 quarters since.
- Erste Asset Management's Passage Bio position peaked at $3.34M in Q4 2021.
- 30 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.
Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.